These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782 [TBL] [Abstract][Full Text] [Related]
3. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Shen C; Hu L; Xia L; Li Y Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
5. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355 [TBL] [Abstract][Full Text] [Related]
6. Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR. Cerna M; Holubec L; Pesta M; Kormunda S; Topolcan O; Cerny R Anticancer Res; 2006; 26(1B):803-8. PubMed ID: 16739357 [TBL] [Abstract][Full Text] [Related]
7. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
8. Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer. Sadahiro S; Suzuki T; Ishikawa K; Saguchi T; Maeda Y; Yasuda S; Makuuchi H; Yurimoto S; Murayama C Ann Surg Oncol; 2005 Dec; 12(12):988-94. PubMed ID: 16244799 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer. Liu ZP; Li LM; Liu XL; Zhang DX Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974 [TBL] [Abstract][Full Text] [Related]
10. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822 [TBL] [Abstract][Full Text] [Related]
11. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796 [TBL] [Abstract][Full Text] [Related]
12. Detection of cancer cells in the peripheral blood of gastric cancer patients. Ikeguchi M; Ohro S; Maeda Y; Fukuda K; Yamaguchi K; Shirai H; Kondo A; Tsujitani S; Kaibara N Int J Mol Med; 2003 Feb; 11(2):217-21. PubMed ID: 12525881 [TBL] [Abstract][Full Text] [Related]
13. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. Kawamata H; Uchida D; Nakashiro K; Hino S; Omotehara F; Yoshida H; Sato M Br J Cancer; 1999 May; 80(3-4):448-52. PubMed ID: 10408852 [TBL] [Abstract][Full Text] [Related]
14. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. Ito H; Kanda T; Nishimaki T; Sato H; Nakagawa S; Hatakeyama K J Exp Clin Cancer Res; 2004 Sep; 23(3):455-64. PubMed ID: 15595636 [TBL] [Abstract][Full Text] [Related]
15. [CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance]. Na GW; Li J; He KJ; Li HH; Zhao XN; Li XW; Mi HN Ai Zheng; 2004 Nov; 23(11):1350-3. PubMed ID: 15522189 [TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients. Bustin SA; Gyselman VG; Siddiqi S; Dorudi S Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338 [TBL] [Abstract][Full Text] [Related]
17. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients]. Zhang XW; Fan P; Yang HY; Yang L; Chen GY Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992 [TBL] [Abstract][Full Text] [Related]
19. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer]. Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients. Tamura N; Iinuma H; Takada T Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]